 Mesenchymal stem cells, MSCs, are multi-potent adult stem cells found in many tissues such as bone marrow, fat and muscle. They have the ability to differentiate into multiple types of cells, including osteoblasts, chondrocytes, myocytes and adipocytes. These cells are of great interest due to their potential for regenerative medicine, as they can be harvested from a patient's own body and used to treat a wide range of conditions. MSCs can also reduce inflammation and promote healing by secreting various immunosuppressive factors. Additionally, MSCs can be administered intravenously to target specific areas of the body, allowing for faster and more efficient delivery of the cells to the site of injury. MSCs have been shown to improve outcomes in several clinical trials, making them a promising treatment option for a variety of diseases and injuries. This article was authored by Devon Empatel, Jaini Shah and Anand S. Srivastava.